Context Therapeutics Insider Trades
NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Context Therapeutics insider activity
No Context Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Lehr Martin A. (Chief Executive Officer) buying 100,000 shares at $0.7008 on Jun 9, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CNTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CNTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 9, 2025 | Lehr Martin A.Chief Executive Officer | Buy | 100,000 | $70.08K | Form 4 |
| Jun 6, 2025 | Minai-Azary Jennifer LynnChief Financial Officer | Buy | 40,010 | $25.49K | Form 4 |
| Jun 6, 2025 | Levit Alex C.Chief Legal Officer, Corp. Sec | Buy | 20,000 | $11.52K | Form 4 |
| Feb 21, 2023 | Lehr Martin A.Chief Executive Officer | Buy | 5,823 | $4.90K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4